Mitchell C. Posner to Immunotherapy
This is a "connection" page, showing publications Mitchell C. Posner has written about Immunotherapy.
Connection Strength
0.315
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
Score: 0.213
-
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance. Oncotarget. 2016 Jul 12; 7(28):43039-43051.
Score: 0.097
-
Gene therapy of cancer: a pilot study of IL-4-gene-modified fibroblasts admixed with autologous tumor to elicit an immune response. Hum Gene Ther. 1994 Jan; 5(1):41-55.
Score: 0.005